BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 6605302)

  • 1. Divergence in activation by poly I:C of human natural killer and killer cells.
    Edwards BS; Borden EC; Smith-Zaremba K
    Cancer Immunol Immunother; 1982; 13(3):158-63. PubMed ID: 6925981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How cytotoxic T cells release their dying targets.
    Nat Immunol; 2023 Sep; 24(9):1413-1414. PubMed ID: 37500889
    [No Abstract]   [Full Text] [Related]  

  • 3. [New insights into cytotoxic effector cells].
    Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
    Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natural cytotoxic cells (NK cells)].
    Frydecka I
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1343-5. PubMed ID: 6371740
    [No Abstract]   [Full Text] [Related]  

  • 5. Spontaneous cytotoxic T cells in murine spleen-cell cultures. II. Distinguishing between spontaneous cytotoxic T cells and NK cells according to kinetics and target selectivity.
    Ezaki T; Skinner MA; Marbrook J
    Immunology; 1983 Nov; 50(3):351-7. PubMed ID: 6605302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.
    Herbert AG; Le Gros GS; Bidawid S; Watson JD
    Immunology; 1984 Feb; 51(2):377-85. PubMed ID: 6607213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous cytotoxic T cells in murine spleen-cell cultures. I. Some characteristics of effector and precursor cells.
    Ezaki T; Skinner MA; Marbrook J
    Immunology; 1983 Nov; 50(3):343-9. PubMed ID: 6605301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cloned cytotoxic lymphocytes with NK-like activity.
    Acha-Orbea H; Groscurth P; Lang R; Stitz L; Hengartner H
    J Immunol; 1983 Jun; 130(6):2952-9. PubMed ID: 6189907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. II. Separation of natural killer cells and cytotoxic T cells.
    Le Gros GS; Herbert AG; Watson JD
    Immunology; 1984 Jan; 51(1):103-13. PubMed ID: 6606615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers.
    Dennert G; Yogeeswaran G; Yamagata S
    J Exp Med; 1981 Mar; 153(3):545-56. PubMed ID: 7252408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing.
    Birke C; Peter HH; Langenberg U; Müller-Hermes WJ; Peters JH; Heitmann J; Leibold W; Dallügge H; Krapf E; Kirchner H
    J Immunol; 1981 Jul; 127(1):94-8. PubMed ID: 7195412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on natural killer (NK) cells. III. The effects of in vitro culture on spontaneous cytotoxicity of murine spleen cells.
    Bartlett SP; Burton RC
    J Immunol; 1982 Mar; 128(3):1070-5. PubMed ID: 7057032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenogeneic serum-induced mouse T cells that trigger the differentiation of precursor into cytolytic T cells.
    Golstein P; Luciani MF; Rubin B
    J Immunol; 1980 Sep; 125(3):1144-51. PubMed ID: 6967891
    [No Abstract]   [Full Text] [Related]  

  • 15. The haemolytic plaque reduction technique to measure cytotoxicity with hybridoma cells as a target.
    Ezaki T; Marbrook J
    J Immunol Methods; 1982 Nov; 54(3):281-90. PubMed ID: 6757326
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.